[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344393-105":3,"doc-detail-344393-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","correlations-of-m6a-methylation-related-mrnas-with-thyroid-cancer-research-report","Correlations of m6A methylation-related mRNAs with thyroid cancer - research report","","m6A (N6-methyladenosine) RNA methylation is closely linked to tumorigenesis, yet its specific role in the malignant progression of papillary thyroid carcinoma (PTC) without autoimmune thyroid disease (AITD) remains unclear. The study analyzed a randomly selected subset from a cohort of PTC patients to assess global m6A levels and key m6A-methylation factors. Results showed increased global m6A methylation in cancer tissues with IGF2BP2 upregulation, pathway activation, and protein-protein interactions involving IGF2BP2 with FN1 and LAMB3. Significant m6A differences were detected across mRNAs, lncRNAs, and ncRNAs, overlapping with differentially expressed cancer-associated genes such as NUM, highlighting potential biomarkers and therapeutic targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/correlations-of-m6a-methylation-related-mrnas-with-thyroid-cancer-research-report/344393/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/correlations-of-m6a-methylation-related-mrnas-with-thyroid-cancer-research-report/344393.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this study?","Question",{"text":63,"@type":64},"The study investigates how m6A methylation-related RNAs correlate with thyroid cancer, specifically in papillary thyroid carcinoma patients without autoimmune thyroid disease.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the researchers observe about global m6A methylation?",{"text":68,"@type":64},"Cancerous tissues showed a significant increase in global m6A methylation compared with para-cancerous tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"Which key gene and interactions were highlighted?",{"text":72,"@type":64},"The m6A “reader” gene IGF2BP2 was upregulated, and a significant protein-protein interaction was observed between IGF2BP2 and cancer-related genes, especially FN1 and LAMB3.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344393,1790173216,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728",8,"[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCorrelations of m6A methylationrelated mRNAs with thyroid cancer  \nZhen Jiang1,2,3,4,5,6,9, Sheng Luo7,9, Yingruo Lin1,9, Huihao Zhang8􀀍 & Ruhai Yi1,2,3,4,5,6􀀍  \nN6-methyladenosine (m6A) RNA methylation plays a crucial role in tumorigenesis. However, the specific role of m6A modifications in the malignant progression of papillary thyroid carcinoma (PTC) without autoimmune thyroid disease (AITD) remains unclear. We analyzed a randomly selected subset of three pairs from a total cohort of 26 pairs of cancerous and para-cancerous tissues from patients with PTC without AITD to investigate global m6A levels and the gene expression of key factors driving m6A methylation. Our results revealed a significant increase in global m6A methylation in cancerous tissues, accompanied by upregulation of the m6A “reader” gene IGF2BP2 . Of the 486 upregulated and 39 downregulated genes identified in cancerous tissues, most of the top-enriched pathways were associated with activated genes and contributed to cancer progression. A significant protein–protein interaction between IGF2BP2 and several key cancer-related genes, particularly FN1 and LAMB3, was observed. Moreover, 313 mRNAs, 55 lncRNAs, and 8 ncRNAs exhibited significant m6A methylation differences, overlapping with differentially expressed cancer-associated genes, particularly NUM, which was recently identified as a potential biomarker for PTC. These findings underscore the importance of m6A-related mechanisms and functions in PTC without AITD development and suggest that FN1-, NMU-, and LAMB3-associated pathways may be potential therapeutic targets and molecular mechanisms for this disease.  \nKeywords Thyroid cancer, N6-methyladenosine, Pathway in cancer, RNA modification  \nThyroid cancer (TC) is one of the most common endocrine-related cancers, and its incidence has been increasing worldwide, including low-and middle-income countries1. TC is generally associated with a favorable prognosis, with a 5-year survival rate of approximately 98%2,3. However, a subset of patients continue to develop lymph node metastasis and cancer recurrence, which are the primary causes ofTC-related mortality4. In addition to various genetic alterations, including mutations, copy number gains, and chromosomal rearrangements, TC progression is linked to epigenetic modifications. This association is supported by the widely accepted consensus over the past decade regarding the contribution of environmental factors to TC development5. However, most epigenetic studies on TC have focused on histone modifications of chromatin, as well as DNA and protein modifications6,7, until RNA-level epigenetic modifications were proven to be involved in gene expression regulation in 20118.  \nN6-Methyladenosine (m6A) is the most prevalent epigenetic modification in RNAs in eukaryotes9. It influences various stages of RNA metabolism, including splicing, export, translation, and degradation, ultimately controlling gene expression10. There are three types of m6A regulators that render the modification dynamic and reversible: methylases (writers), demethylases (erasers), and m6A-binding proteins (readers)11. Growing data indicate that m6A modification plays a significant role in controlling the occurrence and progression of tumors12, and several studies have discussed the potential role of m6A as a biomarker or drug target for prognostic prediction and therapy13–15. Several studies have suggested that the aberrant expression of m6A regulators is linked to the occurrence and progression of TC and also significantly contributes to drug resistance16. However, the current evidence regarding the role ofm6A modifications in TC remains inconsistent or even contradictory. For instance, some studies have suggested that METTL3, an m6A writer, drives TC  \n1Department of Endocrinology, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.  \n2","cbCaifmcnh1rQVoS","https://ap.wps.com/l/cbCaifmcnh1rQVoS","pdf",2095325,11,"English","# Introduction\n## Background on thyroid cancer and epigenetic regulation\n## m6A RNA modification and its regulators\n## Rationale: inconsistency in prior evidence and importance of AITD status\n# Results and Findings","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"The study investigates how m6A methylation-related RNAs correlate with thyroid cancer, specifically in papillary thyroid carcinoma patients without autoimmune thyroid disease.\"},{\"question\":\"What did the researchers observe about global m6A methylation?\",\"answer\":\"Cancerous tissues showed a significant increase in global m6A methylation compared with para-cancerous tissues.\"},{\"question\":\"Which key gene and interactions were highlighted?\",\"answer\":\"The m6A “reader” gene IGF2BP2 was upregulated, and a significant protein-protein interaction was observed between IGF2BP2 and cancer-related genes, especially FN1 and LAMB3.\"}]","Correlations of m6A methylation-related mRNAs with thyroid cancer - research report | PDF",1790053587,28,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4afec85caeba31201442a787968d5f3.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/308ea11d8c2fb6a7f4f4eb07e96f59a9.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/399534bc6100ca56e8c572731d3cc0cd.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13637f45152acb98c4ff6a88f94d3b45.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]